Cargando…

Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2

BACKGROUND: Cancer immunotherapy with monoclonal antibodies and chimeric antigen receptor (CAR) T cell therapies can benefit from selection of new targets with high levels of tumor specificity and from early assessments of efficacy and safety to derisk potential therapies. METHODS: Employing mass sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellizzari, Giulia, Martinez, Olivier, Crescioli, Silvia, Page, Robert, Di Meo, Ashley, Mele, Silvia, Chiaruttini, Giulia, Hoinka, Jan, Batruch, Ihor, Prassas, Ioannis, Grandits, Melanie, López-Abente, Jacobo, Bugallo-Blanco, Eva, Ward, Malcolm, Bax, Heather J, French, Elise, Cheung, Anthony, Lombardi, Sara, Figini, Mariangela, Lacy, Katie E, Diamandis, Eleftherios P, Josephs, Debra H, Spicer, James, Papa, Sophie, Karagiannis, Sophia N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194339/ https://www.ncbi.nlm.nih.gov/pubmed/34112739 http://dx.doi.org/10.1136/jitc-2020-002140

Ejemplares similares

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
por: Pellizzari, Giulia, et al.
Publicado: (2019)

Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology
por: Crescioli, Silvia, et al.
Publicado: (2018)

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021)

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model
por: Williams, Iwan P., et al.
Publicado: (2019)

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
por: Chauhan, Jitesh, et al.
Publicado: (2023)

Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)

B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment
por: Chiaruttini, Giulia, et al.
Publicado: (2017)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry
por: Cretu, Daniela, et al.
Publicado: (2014)

Putative autoantibodies in the cerebrospinal fluid of Alzheimer’s disease patients
por: Lim, Bryant, et al.
Publicado: (2019)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

BRAF inhibitors: resistance and the promise of combination treatments for melanoma
por: Griffin, Merope, et al.
Publicado: (2017)

AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody
por: Ilieva, Kristina M., et al.
Publicado: (2019)

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
por: Ilieva, Kristina M., et al.
Publicado: (2018)

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
por: Nakamura, Mano, et al.
Publicado: (2020)

Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016)

Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)

Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
por: Begcevic, Ilijana, et al.
Publicado: (2016)

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
por: Crescioli, Silvia, et al.
Publicado: (2023)

Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis
por: Sohaei, Dorsa, et al.
Publicado: (2023)

Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers
por: Cretu, Daniela, et al.
Publicado: (2015)

An immunologically relevant rodent model demonstrates safety of therapy using a tumour‐specific IgE
por: Josephs, D. H., et al.
Publicado: (2018)

IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)

In Planta Glycan Engineering and Functional Activities of IgE Antibodies
por: Montero-Morales, Laura, et al.
Publicado: (2019)

Generation and Characterization of Native and Sialic Acid-Deficient IgE
por: McCraw, Alex J., et al.
Publicado: (2022)

Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields
por: Ilieva, Kristina M., et al.
Publicado: (2017)

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics
por: Leung, Felix, et al.
Publicado: (2018)

Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate
por: Bax, Heather J., et al.
Publicado: (2020)

Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis
por: Karagiannis, George S., et al.
Publicado: (2012)

Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry
por: Music, Milena, et al.
Publicado: (2020)

Towards personalized tumor markers
por: Kulasingam, Vathany, et al.
Publicado: (2017)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
por: Correa, Isabel, et al.
Publicado: (2018)

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
por: Spicer, James, et al.
Publicado: (2023)

Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
por: Khair, Duaa O., et al.
Publicado: (2019)

Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry
por: Kagedan, Daniel, et al.
Publicado: (2012)

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
por: Vasiliou, Stella K., et al.
Publicado: (2022)

Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling
por: Leuthard, Deborah S., et al.
Publicado: (2018)

IMMU-16. INTRA-TUMOURAL IL-12 DELIVERY ENABLES CAR T-CELL IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA
por: Agliardi, Giulia, et al.
Publicado: (2020)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
por: Hoffmann, Ricarda M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_shhbjg0p91klhqrfoqm62dgk4e